Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Guangdong Provincial People's Hospital
Clinica Universidad de Navarra, Universidad de Navarra
Canadian Cancer Trials Group
MultiCare Health System Research Institute
Zhujiang Hospital
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Fudan University
Children's Oncology Group
Centre Paul Strauss
Mayo Clinic
Baptist Health South Florida
Ohio State University Comprehensive Cancer Center
Canadian Cancer Trials Group
National Taiwan University Hospital
Fudan University
Mayo Clinic
Tempus AI
Roswell Park Cancer Institute
Shanghai Tongji Hospital, Tongji University School of Medicine
Fudan University
Beth Israel Deaconess Medical Center
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
NRG Oncology
The University of Hong Kong-Shenzhen Hospital
Mayo Clinic
Fudan University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
NRG Oncology
Institut Curie
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Canadian Cancer Trials Group
Peking Union Medical College Hospital
Dana-Farber Cancer Institute
Başakşehir Çam & Sakura City Hospital
Mayo Clinic
Children's Oncology Group
Children's Oncology Group